Old Web
English
Sign In
Acemap
>
authorDetail
>
Martin Kwakkelstein
Martin Kwakkelstein
Novartis
Anemia
Gastroenterology
Immunology
Internal medicine
Interim analysis
1
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Multicenter, Randomized, Phase III Study Comparing Imatinib (Glivec) Standard Dose (400 mg/d) with Imatinib High Dose Induction (800 mg/d) Followed by Imatinib Maintenance (400 mg/d) in Patients with Pretreated Ph+/BCR-ABL+ CML in Chronic Phase - Results from the First Planned Interim Analysis (CELSG-CML 11 ISTAHIT Study).
2007
Blood
Andreas L. Petzer
Dominik Wolf
Dominik Fong
Thomas Lion
Irina Dyagil
Zvenyslava Masliak
Darinka Boskovic
Laimonas Griskevicius
Sandra Lejniece
Emil Spasov
Liana Gercheva
Aleksandar Stojanovic
Dontcho Peytchev
Nikolay Tzvetkov
Rasa Griniūtė
Atanas Stanchev
Martin Kwakkelstein
Hanno Ulmer
Guenther Gastl
Show All
Source
Cite
Save
Citations (0)
1